Anti-osteosarcoma trimodal synergistic therapy using NiFe-LDH and MXene nanocomposite for enhanced biocompatibility and efficacy

• Päätekijät: Yani Xu (Tekijä), Lan Yang (Tekijä), Min Li (Tekijä), Haozhou Shu (Tekijä), Na Jia (Tekijä), Yunzhen Gao (Tekijä), Rongying Shi (Tekijä), Xiaojia Yang (Tekijä), Zhirong Zhang (Tekijä), Ling Zhang (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2024-03-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Osteosarcoma is usually resistant to immunotherapy and, thus primarily relies on surgical resection and high-dosage chemotherapy. Unfortunately, less invasive or toxic therapies such as photothermal therapy (PTT) and chemodynamic therapy (CDT) generally failed to show satisfactory outcomes. Adequate...